Background-Slowed Na + current (I Na ) decay and enhanced late I Na (I Na-L ) prolong the action potential duration (APD) and contribute to early afterdepolarizations. Cardiac resynchronization therapy (CRT) shortens APD compared with dyssynchronous heart failure (DHF); however, the role of altered Na + channel gating in CRT remains unexplored. Methods and Results-Adult dogs underwent left-bundle branch ablation and right atrial pacing (200 beats/min) for 6 weeks (DHF) or 3 weeks followed by 3 weeks of biventricular pacing at the same rate (CRT). I Na and I Na-L were measured in left ventricular myocytes from nonfailing, DHF, and CRT dogs. DHF shifted voltage-dependence of I Na availability by −3 mV compared with nonfailing, enhanced intermediate inactivation, and slowed recovery from inactivation. CRT reversed the DHF-induced voltage shift of availability, partially reversed enhanced intermediate inactivation but did not affect DHF-induced slowed recovery. DHF markedly increased I Na-L compared with nonfailing. CRT dramatically reduced DHF-induced enhanced I Na-L , abbreviated the APD, and suppressed early afterdepolarizations. CRT was associated with a global reduction in phosphorylated Ca 2+ /Calmodulin protein kinase II, which has distinct effects on inactivation of cardiac Na + channels. In a canine AP model, alterations of I Na-L are sufficient to reproduce the effects on APD observed in DHF and CRT myocytes.
C ongestive heart failure is associated with profound abnormalities in both cardiac rhythm and contractile function. The hallmark of cells and tissues isolated from failing hearts independent of the cause is prolongation of action potential duration (APD) attributable to ion channel remodeling, 1 which is highly arrhythmogenic with frequent aberration of repolarization, such as exaggerated spatial and temporal heterogeneity of repolarization, and early afterdepolarizations (EADs) and delayed afterdepolarizations. 2 Ion channel remodeling, especially K + channel downregulation has been consistently demonstrated in human 3 and animal models of heart failure. 4 Slowed Na + current (I Na ) decay and enhanced late I Na (I Na-L ) prolong the action potential (AP) 5 and contribute to the high frequency of EADs. 6 Increased I Na-L and elevated cytosolic Na + ([Na + ] i ) in heart failure are linked with cellular Ca 2+ overload via the reverse mode of the Na + -Ca 2+ exchange 7 and with reactive oxygen species (ROS) generation 8, 9 as well as altered mitochondrial biogenesis. However, the role of Na + current dysfunction in heart failure progression and arrhythmia predisposition is incompletely understood.
Dyssynchronous ventricular contraction in heart failure (DHF) alters the electric phenotype and enhances the susceptibility to ventricular tachycardia or ventricular fibrillation. In patients who experience improvement in contractile synchrony, cardiac resynchronization therapy (CRT) improves symptoms, ventricular function and survival in patients with heart failure, and is expected to reduce frequency of arrhythmias and number of appropriate implantable cardioverter defibrillator shocks. 10 We and others have shown that CRT using biventricular pacing in patients with heart failure and intraventricular conduction delays and acutely increases left ventricular (LV) ejection fraction [11] [12] [13] with a reduction in myocardial oxygen consumption. 14 More recently, we characterized the LV regional remodeling of the cellular electrophysiology in DHF and CRT-induced reverse remodeling. 15 APs were significantly prolonged in DHF, particularly in cells isolated from the lateral (LTR) LV wall; CRT significantly shortened the AP and reduced the LV regional heterogeneity in AP duration, which is consistent with another more chronic model of CRT in nonischemic cardiomyopathy. 16 In this study, we hypothesized that CRT restores the DHFinduced altered Na channel gating and, thus, abbreviates the AP and suppresses EADs. We further explore the role of CaM/ Ca 2+ /Calmodulin protein kinase II (CaMKII) signaling and oxidant stress, known to alter Na channel inactivation, in the salutary effect of CRT on the cellular electrophysiology of the failing ventricle.
Materials and Methods
Canine Tachypacing-Induced Heart Failure Model All protocols followed the US department of Agriculture and National Institutes of Health guidelines, and were approved by the Animal Care and Use Committee of the Johns Hopkins Medical Institutions. The canine models of DHF or CRT have been previously described and represent models of heart failure with dyssynchronous ventricular contraction (DHF) and synchronous contraction (CRT). [17] [18] [19] In brief, adult male mongrel dogs underwent left bundle-branch radiofrequency ablation and the right atrial pacing (200 beats/min) for 6 weeks (DHF dogs: n=7), or 3 weeks of right atrial pacing followed by 3 weeks of resynchronization by biventricular pacing at same pacing rate (CRT dogs: n=7). 15 Control (nonfailing [NF]) dogs (n=4) underwent no tachypacing and no ablation.
Whole-Cell Patch Clamp Recording
Mid-wall LV anterior (ANT) and LTR myocytes from normal (NF), DHF, and CRT dogs were studied using the whole-cell patch clamp. Ventricular myocytes were current and voltage clamped in the wholecell configuration of the patch clamp as previously described. 15, 20 Voltage and current clamp control and data acquisition were performed using custom-written software. For the measurement of APs, ventricular myocytes were current clamped with borosilicate glass electrodes with tip resistances of 3.0 to 4.0 mol/LΩ when filled with pipette solution, and the stimulation frequency was varied over cycle lengths of 2.0, 1.0, 0.5, and 0.25 s. The steady-state APs were recorded and analyzed ≥1 minute after pacing at each cycle length in standard Tyrode's solution (37ºC).
I Na recording was performed at room temperature with patch pipettes with tip resistances of 1 to 1. In all experiments, recording was begun 10 to 15 minutes after establishment of the whole-cell mode to permit stabilization of current amplitude, voltage dependence, and kinetics of gating. Standard voltage protocols were used for assessment of the voltage-dependence of activation/inactivation, recovery from inactivation, and entry into inactivation. To determine the membrane potential of half inactivation (V 1/2 ) and the slope factor k, activation or steady-state inactivation data were fit with a Boltzmann function of the form:
Recovery from inactivation data was fit with a biexponential function of the form: G/G max or I(t)/Imax=A1·exp(−t/ 1)+A2·exp(−t/ 2)+A3, using a nonlinear least squares minimization. The decay phase of the current during a voltage step was fit with biexponential function of the form: I(t)=A f ·exp(−τ/f)+A s ·exp(−τ/s), where A f and A s are the fractions of fast and slow inactivating components, respectively. Persistent (late) I Na was the tetrodotoxin (30 μmol/L)-sensitive current elicited by 800 ms depolarizations to −20 mV (from −140 mV), from 100 to 500 ms after a depolarizing voltage step normalized to the peak I Na .
Molecular Analysis
Canine Na V 1.5 steady-state mRNA levels were measured by kinetic real-time polymerase chain reaction of RNA in tissue isolated from the midmyocardial layer of LV ANT and LTR walls in NF, DHF, and CRT dogs. Na V 1.5, and CaMKII proteins were measured by Western immunoblotting. Detailed methods are provided in the online-only Data Supplement.
Computational Model
Simulations were performed using a modified version of the canine coupled model incorporating local control of Ca 2+ -induced Ca 2+ release. 21 This model was modified by replacing its description of I Na with a new Na + channel representation, based on that of Grandi et al 22 ( Figure I in the online-only Data Supplement). The model is further described in the online-only Data Supplement.
Statistical Analysis
Differences among the 3 groups were compared by 1-way ANOVA with the Bonferroni test. Bonferroni-corrected comparisons were performed only if the overall comparison was statistically significant. Two-group analysis was performed by unpaired or paired t test as appropriate ( Figures 3D and 4B , respectively). Data were expressed as mean±SD or mean±SEM as indicated in each of the figures. A value of P<0.05 was considered significant. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agreed to the article as written.
Results

Changes of I Na Availability by DHF and CRT
There is no significant difference in the gating parameters between ANT and LTR cells in I Na , and this study focused on the difference in Na + currents between NF, DHF, and CRT conditions. Figure 1A shows representative whole-cell I Na in ventricular myocytes from NF, DHF, and CRT dogs. The current-voltage (I-V) relationship of cardiac I Na revealed no significant difference in the peak and reversal potential of the I Na between NF, DHF, and CRT conditions ( Figure 1B ). Furthermore, no significant difference was found in the voltage-dependence of Na + current activation in each group ( Figure 1C ; Table 1 ). On the contrary, DHF produced ≈−3 mV shift in I Na steady-state inactivation compared with the NF dog (V 1/2 ; −74.5±3.2 versus −71.1±3.8 mV; P<0.05; Figure 1D ; Table 1 ), whereas CRT normalized the DHF-mediated hyperpolarizing shift of steady-state inactivation relationship (−70.6 ±0.2.9 mV; P<0.05 versus DHF).
In DHF, I Na had a slower recovery from inactivation, and with a hastened entry into inactivation as compared with NF ( Figure  1E ; Table 1 ). The fast time constant of recovery from inactivation (τ fast ) was significantly larger in DHF than in NF (τ fast ; 7.59±2.88 versus 4.54±0.95 ms; P<0.05). Overall CRT did not significantly alter τ fast compared with DHF (Table 1) . Table 2 and Figure 1F summarizes the effect of DHF or CRT on the entry of cardiac Na + channels into inactivated states. DHF increased the fraction of channels undergoing slow inactivation compared with NF cells (y0: 0.74±0.08 DHF versus 0.83±0.05 NF; P<0.05).
Myocytes from CRT hearts exhibited intermediate entry into slow inactivated states with a statistically significantly larger fraction of current entering intermediate inactivated states compared with cells from NF hearts. Consistent with a global rather than regional alteration, CRT-induced changes in I Na kinetics and gating were similar in cells from the ANT and LTR walls.
Changes of Decay Time Constant by DHF and CRT
As shown in Figure 2A , DHF slowed I Na decay compared with NF, and CRT normalized the DHF-induced change of I Na decay. The initial (τ fast ) and late (τ slow ) time constants of I Na decay over a range of voltages are shown in Figure  2B and Table 1 . There was no significant difference in the τ fast between the groups, whereas τ slow was significantly increased in DHF compared with NF (13.91±6.80 versus 4.44±3.62 ms; P<0.05), and CRT normalized the DHFinduced change of I Na decay (5.02±4.37 ms). No significant difference was observed in these time constants between ANT and LTR cells. (10) CRT (7) C E P2/P1 Figure 1 . Cardiac resynchronization therapy (CRT) partially reverses dyssynchronous heart failure (DHF)-induced alterations in Na + currents. A, Representative families of Na + currents (I Na ) in myocytes from nonfailing (NF), DHF, and CRT dogs. Cells were held at −120 mV, and currents were elicited by 50 ms test pulses to potentials ranging from −100 to +40 mV. B, Peak current-voltage (I-V) relationships of I Na in NF, DHF, and CRT ventricular myocytes. C and D, The voltage-dependence of activation (G/G max ; C) and steady-state inactivation (I/I max ) of I Na in NF, DHF, and CRT myocytes (D). E, The time course of recovery from inactivation of I Na . F, Kinetics of entry into slow inactivated states of I Na in NF, DHF, and CRT ventricular myocytes. The values in parentheses are the number of cells studied in this and all remaining figures.
Change of Late I Na (I Na-L ) by DHF and CRT Figure 3A shows the superimposed persistent I Na-L in myocytes from NF, DHF, and CRT canine ventricles ([Na
I Na-L was elicited by 800 ms depolarizations to −20 mV (from −140 mV), and tetrodotoxin-sensitive currents were normalized to peak I Na . The current integral was calculated between 100 and 500 ms after the depolarizing pulse. As shown in Figure 3B and Table 3 , DHF significantly increased I Na-L compared with NF (1.33±0.66% versus 0.09±0.10%; P<0.05), but this increase was virtually eliminated in CRT myocytes (0.42±0.21%; P<0.05 versus DHF).
We then studied I Na-L in physiological bath solution
. I Na-L was elicited by 2000 ms depolarizations to −40 mV (from −140 mV). I Na-L was measured as the average amplitude of the current between 200 and 220 ms. DHF significantly increased I Na-L in physiological Na + conditions (0.16±0.08-0.82±0.26 pA/pF; P<0.05 versus NF), and CRT dramatically reduced the DHF-induced increase of I Na-L (0.23±0.16 pA/pF; P<0.05 versus DHF). To demonstrate the I Na-L increase in heart failure, we measured I Na in [Na + ] o =140 mmol/L at baseline and after ranolazine, which is known to block I Na-L . Ranolazine (1 μmol/L) reduced I Na-L in myocytes from DHF (0.82±0.25-0.37±0.15 pA/pF; P<0.05) but not in myocytes isolated from NF or CRT hearts ( Figure 3C  and 3D ). There were no regional differences in I Na-L in ANT and LTR cells in either [Na + ] o =10 mmol/L and 140 mmol/L conditions.
APD Prolongation and Late I Na
Normal impulse formation and conduction depend on the fast inward I Na . Also, an increase in I Na-L can markedly prolong APD and promote polymorphic ventricular tachycardia. AP prolongation in DHF is highly arrhythmogenic with frequent EADs that were not observed in myocytes isolated from NF hearts. CRT partially abbreviated the DHF-induced APD prolongation and reduced the frequency of EADs in cells isolated from both the ANT and LTR LV. 4, 15 To understand the contribution of I Na-L to prolongation of the AP in DHF and CRT, we added ranolazine to the bath solution during continuous AP recording. Shown in Figure 4A , ranolazine (1 μmol/L) did not change the APD in myocytes from NF; however, it significantly shortened APD in cells isolated from DHF hearts ( Figure 4B and 4C), consistent with an increase of I Na-L having a substantial role in APD prolongation in DHF. Myocytes from CRT hearts had a reduced I Na,L density compared with DHF, thus, ranolazine had less effect on APD and EADs in cells from these hearts compared with DHF ( Figure 4D ).
CRT has a number of effects on electric remodeling in the failing heart, including reversal of K + channel downregulation and improvement of SR Ca handling. 15 To determine whether the changes in I Na-L could explain the changes in APD, we used a mathematical model of the canine AP. 21, 22 Increasing normalized I Na-L from 0.11% to 0.88% of the peak I Na reproduced APD prolongation similar to that observed in myocytes from DHF hearts. An intermediate normalized I Na-L of 0.35% of peak current shortened the APD compared with DHF, similar to that observed in CRT. The simulations are consistent with changes of I Na-L in heart failure contributing to APD prolongation in DHF and its abbreviation by CRT ( Figure 4E ).
Ca
2+ /Calmodulin Protein Kinase II
Heart failure is associated with global 23 and regional 19, 24 increases in CaMKII activity that are partially reversed by CRT. 19 CaMKII modulates the function of Na currents, producing an increase in I Na-L 20, 25 ; therefore, we propose that changes in CaMKII expression in myocytes are linked to alteration in the Na current phenotype in NF, DHF, and CRT myocytes. As shown in Figure 5 , DHF increased total and phosphorylated (pThr287) CaMKII compared with NF. Notably, CRT significantly reduced the DHF-induced increase of CaMKII pThr287 with a trend in a reduction in total CaMKII. No significant regional differences between ANT and LTR regions of the LV were found in any group.
Discussion
The failing heart is characterized by a number of changes in its electrophysiological function, prominently prolongation of the AP and delayed repolarization. This is attributed to a number of changes in ionic and transporter currents described in heart failure, 3, 4 and these prominently include changes in the density and gating of the Na + current. 26, 27 We previously reported that resynchronization of mechanical contraction by biventricular pacing of the failing heart, despite persistence of global LV dysfunction, reverses (12) DHF (13) CRT ( detrimental remodeling of ion channel function and calcium handling. 15 In this study, we demonstrated that CRT reverses the DHF-induced alterations of the Na + current and, in particular, attenuates the increase of I Na-L associated with DHF, thus abbreviating the APD and reducing the frequency of EADs. The changes in Na + channel gating are associated with a reduction in activated, autophosphorylated CaMKII in CRT.
I Na Remodeling in DHF and CRT
Normal impulse formation and conduction as well APD depend on the inward I Na . Studies of I Na regulation in heart failure have been somewhat variable and model dependent. In this study, we found peak current was not significantly altered, although others have reported downregulation in a similar model. 27 However, we did observe slowing of the decay and rise in late current, and this has been observed in a canine myocardial infarction model of heart failure and in failing human hearts. 26, 28, 29 An increase in the late component of Na + current (I Na-L ) can markedly prolong APD and facilitate the generation of EADs and promote polymorphic ventricular tachycardia. 30 Therefore, changes in I Na density and kinetics may predispose to arrhythmias either by disrupting conduction and prolonging repolarization. In this study, the increase of I Na-L by DHF prolonged APD, although CRT partially normalized I Na-L , and abbreviated the APD.
Ranolazine is an inhibitor of a number of ion channels with relative selectivity for I Na-L and antiarrhythmic effects in vitro. 31, 32 In an ischemic canine model of HF, ranolazine improved abnormal repolarization and contraction in LV myocytes. 33 Consistent with CRT modifying I Na-L as key mechanism for electric reverse remodeling, we found that ranolazine suppresses I Na-L and, at a low dose, completely normalized the APD and prevented EADs in acutely isolated DHF myocytes. In cells from NF and CRT hearts with significantly less I Na-L , the drug had little effect on the APD. Simulations of the experimentally determined changes in the magnitude of I Na-L in a canine AP model for each condition predicted prolongation of the APD in DHF, albeit larger than that observed experimentally. The quantitative contribution of the increase in I Na-L to APD is complex, but reproduces the AP prolongation in DHF and the partial reversal of the APD prolongation in CRT myocytes. The data, which are consistent with a global reduction in APD and hastening of repolarization by CRT, suggest a mechanism for the antiarrhythmic properties of this pacing therapy. The data do not allow us to speak to the role of ranolazine as an antiarrhythmic therapy in this model because we used a concentration of the drug designed to affect only I Na-L and not other changes in the Na current or other currents that are remodeled in heart failure.
CaMKII and Oxidant Stress
Among the many signaling changes in the failing heart, an increase in CaMKII protein levels and activity has been regularly observed. 34 A mechanistic link between the increase in CaMKII activity and I Na-L that is observed in human and canine heart failure is suggested by recent studies showing that intracellular CaMKII signaling increases I Na-L and Na + influx in failing myocytes by slowing inactivation kinetics and shifting steady-state inactivation. 20, 25, 35 In our study, consistent with these previous results, DHF is associated with an increase CaMKII activity; moreover, CRT partially normalizes CaMKII activity indexed by a reduction in the autophosphorylated forms of the enzyme (Figure 5 ), at the same time reducing the amplitude of I Na-L . The data support a critical role of CaMKII and its regulation in the remodeling and reverse electric remodeling of ventricular myocyte electrophysiology by DHF and CRT, respectively. 19, [36] [37] [38] Oxidative stress is linked to the progression of heart failure, and mitochondria are a critical source of ROS in failing myocardium. Blocking I Na-L reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. 9, 39 Oxidative stress-induced afterdepolarizations are directly linked to CaMKII activity. 40, 41 Furthermore, Kohlhaas et al 42 suggest that increased [Na + ] i in heart failure promotes ROS formation by reducing mitochondrial Ca 2+ uptake. 43 Cardiac resynchronization of the failing heart potently alters the mitochondrial proteome with an associated improvement in mitochondrial function reflected in an increase in the respiratory control index. 44 Moreover, DHF is associated with global and region activation of stress-related proteins, and CRT reduces stress kinase activation. 19, 24 We did not directly measure ROS in these studies; however, our findings suggest a mechanism of remodeling in DHF characterized by an ROSand CaMKII-mediated increase of I Na-L , and that is reversed by a reduction in CaMKII activity decreasing I Na-L and suppressing EADs in CRT.
Limitations
One limitation in this study is the absence of a direct measurement of oxidant levels in the tissue; however, our recent study demonstrating that resynchronization improved mitochondria oxidative phosphorylation coupling 44 suggests that CRT may suppress ROS level in the heart failure. Second, as we have shown previously, CRT improves multiple ion channel and Ca 2+ handling abnormalities in DHF, 15 and the functional effects on cardiac electrophysiology are complex and interrelated. Therefore, we used computer simulations to quantify the effect of reverse remodeling of Na + current in the context of the changes in other ionic currents and transporters in our models of DHF and CRT. An isolated change in I Na-L in the simulated AP is sufficient to dramatically alter the duration consistent with a significant contribution of I Na-L to prolongation of AP in the failing heart but is certainly not the only change that influences the APD in DHF and CRT.
Clinical Implications
CRT is a remarkable therapy that improves symptoms and survival in a subset of patients with heart failure associated with dyssynchronous mechanical contraction. The mechanical act of resynchronizing contraction by pacing has significant effects on cellular signaling in the failing heart that are associated with not only improved mechanical performance but also enhanced energetic efficiency. This provides an explanation for the mechanism of action of CRT in heart failure and identified pathways that are central to improving cardiac function and which could be approached pharmacologically in patients that do not respond to CRT. In addition, a role for I Na-L in the AP prolongation associated with DHF and its reversal by CRT in the setting of improved mechanical and electric performance of the heart suggest a pathogenic role of the late Na + current in arrhythmias in heart failure that could be addressed not only by CRT, but also by pharmacological agents that target this current component.
